N‐acetylcysteine vs control
Early all‐cause mortality (≤ 3 months) Reported at: 30 days · adults with acute respiratory distress syndrome
It is very uncertain whether N‐acetylcysteine changes early all‐cause mortality (≤ 3 months) Reported at: 30 days compared with control (very low certainty).
1 finding from 1 review
- Pharmacological agents for adults with acute respiratory distress syndrome 2019 · Cochrane Headline outcomes onlyRR 0.64 [0.32, 1.3]1 study · 36 participantsVery low